Progyny, Inc. (PGNY)
NASDAQ: PGNY · IEX Real-Time Price · USD
29.14
+0.54 (1.89%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Progyny Market Cap
Progyny has a market cap or net worth of $2.77 billion as of July 26, 2024. Its market cap has decreased by -25.00% in one year.
Market Cap
2.77B
Enterprise Value
2.41B
1-Year Change
-25.00%
Ranking
Category
Stock Price
$29.14
Market Cap Chart
Since October 25, 2019, Progyny's market cap has increased from $1.31B to $2.77B, an increase of 111.83%. That is a compound annual growth rate of 17.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 2.77B | -22.13% |
| Dec 29, 2023 | 3.56B | 23.15% |
| Dec 30, 2022 | 2.89B | -36.46% |
| Dec 31, 2021 | 4.55B | 23.98% |
| Dec 31, 2020 | 3.67B | 59.18% |
| Dec 31, 2019 | 2.31B | 76.13% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| agilon health | 2.83B |
| Morphic Holding | 2.83B |
| SpringWorks Therapeutics | 2.82B |
| MoonLake Immunotherapeutics | 2.81B |
| Envista Holdings | 2.80B |
| MorphoSys AG | 2.77B |
| Geron | 2.76B |
| Evolent Health | 2.75B |